載入...
Risk Factors for Delayed Elimination of Methotrexate in Children, Adolescents and Young Adults With Osteosarcoma
Background/Aim: High-dose methotrexate (HD-MTX) is pivotal chemotherapy in the treatment of patients with osteosarcoma. Blood concentrations of MTX are associated with several side effects, but there are large individual differences in the elimination of MTX. The aim of this study was to explore ris...
Na minha lista:
| 發表在: | In Vivo |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
International Institute of Anticancer Research
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7811654/ https://ncbi.nlm.nih.gov/pubmed/33144454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12185 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|